Number of Shares
878,897.00
Current Holdings Value*
$6.65 Mil
% of Portfolio
2.75%
Total Estimate Gain
$-8.52 Mil
% of Total Estimate Gain
-55.28%

Patient Square Capital LP's Cullinan Therapeutics Inc Holding Summary

As of 2025-03-31, Patient Square Capital LP held 878,897.00 shares of Cullinan Therapeutics Inc(CGEM), totaling $6.65 Mil. This investment constitutes 2.75% of their stock portfolio, and Patient Square Capital LP now holds 1.49% of the outstanding Cullinan Therapeutics Inc(CGEM) stock.

The initial trade took place in 2024Q3. And since then Patient Square Capital LP has made 2 purchases of CGEM, at an average price of $17.53, for a total of 878,897.00 shares. Based on historical transaction data and CGEM's current price of $7.84, Patient Square Capital LP's estimated gain on his CGEM holdings is $-8.52 Mil, reflecting a -55.28% gain to date.

Patient Square Capital LP CGEM ($7.84) Holding Chart

Patient Square Capital LP CGEM ($7.84) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1